EP Patent
EP3366278B1 — Aqueous suspensions of tmc278
Assigned to Janssen Sciences Ireland ULC · Expires 2024-08-07 · 2y expired
What this patent protects
Patent listed against Vocabria.
Drugs covered by this patent
- Vocabria (CABOTEGRAVIR) · GSK
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.